Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jul 15;26(14):3890.
doi: 10.1158/1078-0432.CCR-20-1219.

5-FU, Irinotecan, Nab-Paclitaxel in Gastrointestinal Cancers-Response

Manish R Sharma  1 , Smita S Joshi  2 , Hedy L Kindler  2
Affiliations
Comment

5-FU, Irinotecan, Nab-Paclitaxel in Gastrointestinal Cancers-Response

Manish R Sharma et al. Clin Cancer Res. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure of potential conflicts of interest (same as for the original manuscript): H.L. Kindler is an employee/paid consultant for Inventiva, AstraZeneca, Aldeyra Therapeutics, Aduro Biotech, Boehringer-Ingelheim, Bristol-Myers Squibb, Erytech, Five Prime Therapeutics, Ipsen, Kyowa, Merck, and Paredox. M.R. Sharma is an employee/paid consultant for Ipsen, Bayer, AbbVie, Taiho, Eisai, and Exelixis. No potential conflicts of interest were disclosed by the other authors.

Comment on

References

    1. Toffoli G, et al. Genotype-Guided Dosing Study of FOLFIRI plus Bevacizumab in Patients with Metastatic Colorectal Cancer. Clin Cancer Res 23, 918–924 (2017). - PMC - PubMed
    1. Sharma MR, et al. A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies. Cancer 125, 1629–1636 (2019). - PubMed